Pioneering
PATIENT-CENTRIC Medicines
Azurity specializes in providing innovative, high-quality products that address the specific needs of underserved patient segments.
Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.
Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.
Medicine that’s RIGHT FOR OUR PATIENTS.
Azurity’s products have benefited millions of patients whose needs are not served by other commercially available therapies.
Azurity currently offers a comprehensive product portfolio that serves multiple therapeutic areas, with more on the way!
FDA-APPROVED PRODUCTS
A growing portfolio of products designed to fulfill unmet needs of patients.
NON-FDA APPROVED FIRST® COMPOUNDING KITS
A family of prescription compounding kits designed as an alternative to conventional dosage forms.
Pharmacist to Pharmacist
Challenged by the ever-changing compounding landscape? Don’t be. Click to learn How FIRST® Kits Help Pharmacists – professionals like you – facilitate their obligations under 503A and USP <795>.
Visit our resource center now to learn more
Compounding made convenient & consistent.
Pharmacist to Pharmacist
Challenged by the ever-changing compounding landscape? Don’t be.
Click to learn How FIRST® Kits Help Pharmacists – professionals like you – facilitate their obligations under 503A and USP <795>.
Visit our resource center now to learn more
Compounding made convenient & consistent.
News & Events
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Woburn, Mass. – February 17, 2022 – Azurity Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing innovative medicines that meet the specific needs of underserved…
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF FLEQSUVY™
(baclofen oral suspension)
WOBURN, MA, February 7, 2022 Azurity Pharmaceuticals, Inc., a private specialty pharmaceutical company, focused on developing innovative products to meet the unique needs of patients with underserved…
